Publications
- Experience with ruxolitinib in the treatment of myelofibrosis and polycythaemia vera at Czech haematological institutions2017 | Faculty of Medicine in Hradec Králové
- Lenalidomide treatment in myelodysplastic syndrome with 5q deletion - Czech MDS group experience2015 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
- Impact of immunomodulatory drugs in treatment of primary myelofibrosis2015 | Faculty of Medicine in Hradec Králové
- New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine2011 | Faculty of Medicine in Hradec Králové
- The role of hepcidin in the diagnosis and treatment of anemias2011 | Faculty of Medicine in Hradec Králové
- A case report of severe pancytopenia with predominant megaloblastic anemia caused by malnutrition2011 | Publication without faculty affiliation
- Differential diagnosis of anemia +1Publication without faculty affiliation
- Research Report University Hospital clinical trial AZA-MDS-003Publication without faculty affiliation
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
- The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib2024 | First Faculty of Medicine
Loading network view...